Once-Weekly Tirzepatide for Obesity | NEJM |
![]() |
The type 2 diabetes drug tirzepatide has been reported to induce weight loss in patients with diabetes. A new randomized trial reports weight loss with tirzepatide in patients without diabetes.
These findings are summarized in a short video. To see the full article, follow this link: https://nej.md/3mjAbvD |